FERNANDO LIAÑO; ALBERTO MORENO; JOSé LUIS TERUEL; SANTIAGO LAMAS; RAFAEL MATESANZ; JOAQUÍN ORTUÑO
This content is PDF only. Please click on the PDF icon to access.
To the editor: Up to now, 15 cases of hepatic veno-occlusive disease have been reported in recipients of renal transplants treated with azathioprine (1-3). Read and colleagues (1) suggest a direct role of azathioprine in the pathogenesis of this disease. The small number of patients in which this clinicopathologic diagnosis has been established is surprising, however, considering the many thousand of transplant recipients treated with this drug all over the world. Nevertheless, we agree with Read and colleagues that a high index of suspicion is required, especially from the pathologic viewpoint.
Azathioprine and veno-occlusive disease may be only casually related,
LIAÑO F, MORENO A, TERUEL JL, et al. Hepatic Veno-occlusive Disease and Renal Transplantation. Ann Intern Med. 1986;105:625–626. doi: 10.7326/0003-4819-105-4-625
Download citation file:
Published: Ann Intern Med. 1986;105(4):625-626.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use